1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin.

doi:10.1097/FJC.0b013e3181761906

Article

1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin.

Journal of cardiovascular pharmacology - 1 Jun 2008

Mancuso Peter, Rahman Ayesha, Hershey Stephen D, Dandu Loredana, Nibbelink Karl A, Simpson Robert U

Abstract excerpt

A number of investigators have observed insufficient 25-hydroxyvitamin D status in patients with congestive heart failure, suggesting a role for vitamin D insufficiency in the pathogenesis of this disorder. We have observed cardiac hypertrophy and collagen accumulation in rats deficient in vitami...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin.

Abstract excerpt

Topics

Related research